1·Dideoxynucleotide is chain-elongating inhibitor of DNA polymerase.
二脱氧核苷酸是 DNA 聚合酶的链延长抑制剂。
2·Kevin is taking the monamine oxidase inhibitor for his depression.
凯文正在服用单胺氧化酶抑制剂来治疗抑郁症。
3·It is lethal to the cell when expressed without its inhibitor barstar.
在没有其抑制剂巴斯塔的情况下表达对细胞具有致命性。
4·The lead drug candidate in FusoGen's pipeline is Sifuvirtide, an HIV fusion inhibitor.
融合素的候选先导药物是西夫韦肽，一种HIV融合抑制剂。
5·They studied the effect of phenylmethylsulfonyl fluoride, a phospholipase C inhibitor, on ischemic injury to brain mitochondria in rats.
他们研究了磷脂酶C 抑制剂苯甲基磺酰氟对大鼠脑线粒体缺血性损伤的作用。
1·Also the combination of different target agents, such as combining the EGFR blockers - such as erlotinib and the cyclooxygenase-2 inhibitor (celecoxib) - needs to be investigated in clinical trials.
联合应用靶向因子如egfr阻滞剂-如厄罗替尼布和环氧化酶2抑制因子(塞来考昔)-还需要临床验证。
2·"If we can use an inhibitor to block ERBB3, then it should be a very potent anti-cancer therapeutic," he said.
“如果我们能使用一种抑制因子阻断ERBB3，那么它应该是一种有潜力的抗癌治疗方法。”他说。
3·We are attracted by the function of inhibitor of apoptosis in carcinoma progression.
凋亡抑制因子在肿瘤进展中的作用日益受到人们的关注。
4·Endostatin is a kind of angiogenesis inhibitor, specific effecting in the new microvascular endothelial cells. The level of endostatin and the angiogenesis of tumor have a close correlation.
内皮抑素是一种抗血管生成的抑制因子，它特异性地作用于新生微血管的内皮细胞，其水平与肿瘤血管生成有着明显的相关性。
5·Progress of proteinase inhibitor of insect, especially the Bombyx mori, is summarized in this article.
概述了昆虫特别是家蚕蛋白酶抑制因子的研究进展。
1·To reverse the memory loss, doctors inject a compound called a histone deacetylase inhibitor.
为了逆转记忆遗失，医生在复合物中添加了组蛋白脱乙酰基酶抑制物。
2·The von Willebrand's disease factors in plasm, adjusted protein of thrombase and inhibitor 1 of activator of plasminogen were detected with enzyme-linked immunosorbent assay.
用酶联免疫吸附法检测血浆血管性假性血友病因子、凝血酶调节蛋白、纤溶酶原激活物抑制物1水平。
3·Dosage: the dosage must be based on the patients' body weight, the presence of inhibitor, the severity of bleeding and other factors.
用量：给药剂量必须参照体重、是否存在抑制物，出血的严重程度等因素。
4·Conclusion The diabetic nephropathy patients have imbalance of plasma plasminogen activator and its inhibitor system.
结论：糖尿病肾病患者存在血浆纤溶酶原激活物及其抑制物系统失衡。